Prodrugs and Soft Drugs - June 9-10, 2005 - Philadelphia, PA

Prodrugs and Soft Drugs
June 9-10, 2005 - Philadelphia, PA
Park Hyatt at the Bellevue, Philadelphia, PA
Effective Delivery Options for Solubility, Targeting, and Managing Toxicity
Prodrugs and soft drugs can solve many of the drug delivery problems your lab currently faces: insoluble drugs, drugs that are too toxic, and drugs that need targeting for toxicity or absorption reasons.
This conference features acknowledged experts in the fields of prodrug and soft drug design, and will help your company build strong and thriving prodrug and soft drug components. The conference will present many in depth case studies filled with scientific information on the development of drugs that are currently on the market.
Here?s what you?ll learn from this conference:
Valentino Stella of U Kansas makes a case for prodrugs for the delivery of drugs with poorly drugable properties.
How Gilead Sciences developed 3 generations of a leading HIV prodrug.
Two researchers detail their efforts on ester-based prodrugs.
Learn how Metabasis developed their liver-targeting Hepatitis C prodrug
How researchers at the Medical University of South Carolina use prodrug technology to fight cancer
Nicholas Bodor detailing rules for the rational design of novel soft drugs
Design of soft estrogens
Novel soft drug applications of cyclosporine A from Enanta Pharmaceuticals
Soft drugs used to treat asthma by Johnson & Johnson
and much more
Who Should Attend
Drug delivery
Drug safety
Formulation
Pharmaceutical chemistry
Medicinal chemistry
Pharmacokinetics
Pharmacology
Process Development
Toxicology